Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)
卡瑞利珠单抗联合化疗与放化疗作为可切除食管鳞状细胞癌新辅助治疗的比较：2期随机试验（REVO）
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-64660-z
Wang, Peiyuan; Chen, Yujie; Wang, Feng; Chen, Mingqiu; Zheng, Buhong; Zhang, Derong; Zheng, Qingfeng; Wang, Jiezhong; Chen, Junqiang; Cai, Huaxin; Liu, Junhua; Zhang, Wenshan; Lian, Changhong; Chen, Juhui; Lin, Yu; Xu, Yuanji; Huang, Rongfang; Lei, Mengxia; Chen, Peng; He, Hao; Lin, Hui; Chen, Xiaofeng; Zhou, Hang; Chen, Weijie; Wei, Wenwei; Zhuang, Fengnian; Lin, Junpeng; Huang, Canhua; Guan, Ni; Yan, Jin; Liang, Shujun; Liu, Shuoyan; Li, Jiancheng
